Darshan Mehta, BQ Prime

Darshan Mehta

BQ Prime

Mumbai, MH, India

Contact Darshan

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

  • Unknown
  • BQ Prime

Past articles by Darshan:

Dr. Reddy’s Stock Jumps After U.S. FDA Clears Andhra Pradesh Plant

Shares of Dr. Reddy’s Laboratories Ltd. jumped to the highest in more than four years after the drugmaker said it received the U.S. regulator’s report that paves the way for fresh approvals for its products and exports to its biggest market. → Read More

Goldman Sachs Lists Buy And Sell Stock Ideas Amid Market Downcycle

Stock Ideas For 2020: Goldman Sachs lists eight India stocks that it thinks are ‘buy’ ideas and four ‘sell’ calls amid a coronavirus-fuelled market downcycle. → Read More

L&T Bags More Orders In First 22 Days Of April Than In Entire Fourth Quarter

L&T announced 10 new orders in the first 22 days of April compared to seven in the previous three months. These orders, likely won before the lockdown, are worth between Rs 18,500 crore and Rs 37,000 crore. → Read More

Cement Makers Resume Operations Amid Lockdown But Demand, Offtake Key

Coronavirus Impact on Cement Sector: Over the last week, several cement makers said they were looking to restart work, or were seeking approval to do so. India’s cement demand is expected to drop 70-80% in April and 20-25% in 2020-21 due to the coronavirus pandemic, Shree Cement’s HM Bangur said. → Read More

Q4 Earnings Preview: India Inc. Stares At A Muted Quarter Amid Virus Outbreak

Most analysts expect India Inc.’s earnings to drop in the quarter ended March as the new coronavirus pandemic shut businesses temporarily in an economy that’s set to grow at its slowest pace in a decade. → Read More

Cipla Gets U.S. FDA Nod For Generic Inhaler Amid Coronavirus Pandemic

U.S. FDA has approved Cipla’s generic version of Merck’s commonly used inhaler in light of the coronavirus pandemic. Cipla is likely to benefit from two factors: limited competition and surge in demand due to the spread of Covid-19 in the U.S. → Read More

India’s Pharma Sales Growth Slows In Lockdown-Marred March

Growth in pharma sales in India slowed in March despite the government allowing sale of only essential items, including medicines, during the three-week coronavirus lockdown period. → Read More

Morgan Stanley Sees $7.1-Billion Inflows Into India On MSCI Rejig

Indian stocks are expected to see an inflow of more than $7 billion on account of a likely increase in their weights on the MSCI Index, according to Morgan Stanley. → Read More

Aurobindo Pharma, Sandoz Terminate U.S. Dermatology, Oral Solid Businesses Deal

Aurobindo Pharma Ltd. said it reached a mutual agreement with Sandoz Inc. to terminate the deal to acquire the Novartis AG subsidiary’s generic oral solids and dermatology businesses in the U.S. → Read More

Sun Pharma Shares Fall After U.S. FDA Setback For Halol Plant

U.S. FDA bars Sun Pharma’s Halol plant in Gujarat from getting any fresh approvals for exports to the American market. Sun Pharma shares fell as much as 7% due to the news but pared most of the losses to end the day 1.35% lower. → Read More

Covid-19 Impact: Morgan Stanley Expects Global Recession In First Half Of 2020

Morgan Stanley expects a deep global recession in the first half of 2020 on the back of disruptions to the economy’s demand and supply sides following the outbreak of the novel coronavirus. Growth could contract by 2.3 percent over the previous year in the first half of 2020, Chetan Ahya wrote in a note dated March 29. → Read More

L&T Faces Risk Of Missing Full-Year Order Guidance Amid Virus Turmoil

L&T after its Q3 results maintained order inflow guidance at 10-12% and revenue at 12-15% for FY20. This, however, before the Indian economy was roiled by coronavirus outbreak and crude oil price war. → Read More

Ashok Leyland Scales Back Hinduja Leyland Finance Stake Purchase Plan

Ashok Leyland Ltd. will pare the stake it intends to acquire in a non-bank lending unit by nearly two thirds after the commercial vehicle maker’s shares plunged the most in over two decades after it announced the deal on March 18. → Read More

Motherson Sumi Says ‘Well-Prepared’ To Deal With Coronavirus Impact

Coronavirus Impact: Motherson Sumi shares were already reeling from the effects of a prolonged auto slowdown in India. Motherson Sumi says its 27 plants in China, barring the one near Wuhan, have returned to normalised levels. → Read More

Cipla Gets U.S. FDA Warning Letter For Goa Unit

Cipla says it has received a ‘warning letter’ from the U.S. drug regulator for its formulations plant in Goa. → Read More

Nifty Q3 Results: The Three Sectors That Proved To Be A Drag

Nifty Q3 Results Analysis: Yes Bank is the only Nifty 50 company that has delayed its Q3 results as it’s weighing a fresh fundraising plan. Here’s a sector-wise analysis of the 49 Nifty 50 companies that have declared their Q3 results. → Read More

This Is What Helped Honeywell Defy The Slowdown

Honeywell Automation India Ltd. defied a slowing economy as it focuses on its infrastructure and pharmaceutical verticals. → Read More

Motherson Sumi To Demerge Its Domestic Wiring Harness Business

The Motherson Sumi demerger is part of a long pending request of Sumitomo Wiring Systems to focus on the wiring harness business in India. → Read More

How Budget 2020 Will Impact Various Sectors

Most analysts expect the government to increase its outlay for various sectors in a bid to revive the slowing economy. → Read More

What Top Brokerages Expect From Budget 2020

Most analysts expect the government to spend more on infrastructure even as they cautioned that the task reviving the sluggish economy while maintaining fiscal discipline is going to be difficult. → Read More